RoosterBio, Inc. aims to radically change the way that scientists use stem cells and to propel the industrialization of regenerative technologies. RoosterBio is enabling living cellular technologies to become more affordable, easier to access, and much simpler to incorporate into product development efforts, leading to a rapid acceleration in products coming to market that incorporate these technologies. Advancements in bioprinting are driving regenerative medicine, and we are providing the cellular bioink in this rapidly developing market. We believe that we can help shape this new market by making stem cells abundant, affordable, and much simpler to translate into the clinic.
High quality stem cells have traditionally been a “scarce resource” in the field, being expensive and time consuming to grow, and requiring the skills of highly trained scientists to obtain quality stem cells. We are driving the transition of stem cells from a scarce resource into an abundant resource, increasing their availability, and decreasing the complexity required to incorporate stem cells into products. We envision a world where stem cells will be used as ready-to-use reagents – much differently than they are used today.
RoosterBio’s translation-friendly products are high volume, affordable, and well-characterized adult human mesenchymal stem cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to time and costs savings for customers. We have demonstrated that our cells can be used directly out of thaw – eliminating the expansion step from initiating an experiment. RoosterBio’s innovative products are ushering in a new era of productivity and standardization into the field, where researchers spend newly found time and money performing more high-value experiments, accelerating the road to discovery in regenerative medicine.